// App-Quantinova.ai

1768 : CN Inhibition (But Not mTOR Inhibition) of a Novel CD8+ T Cell Regulatory Mechanism Results in Higher Alloantibody Posttransplant

Researchers

Presenter

  • J. Zimmerer

Principal Investigators

  • S. Elzein

  • C. Wright

  • G. Bumgardner

Medical Centers

  • Dept of Surgery, CTC, The Ohio State University Wexner Medical Center, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Tacrolimus

  • Rapacan

  • DMSO

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved